YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Uber Technologies, Inc. is undertaking one of its biggest organizational resets in years, cutting jobs, reducing management layers and red…
PDUFA target action date set to 18 December 2026 LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug…
LUND, Sweden, June 1, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that Eli Lilly and Company ("Lilly") has exercised its option to include amylin receptor agonists (amylin) in the collaboration and license agreement ent…
As European markets remain buoyant, with the STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy prevailing, investors are keenly observing potential opportunities amid recent market volatility. In this contex…
Amid continuing optimism about the European economy and company earnings, the pan-European STOXX Europe 600 Index recently ended 2.27% higher, reflecting a favorable interest rate environment. As major stock indexes across Europe rise, ide…
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the N…
As European markets navigate a mixed landscape, with the STOXX Europe 600 Index inching higher amid hopes for interest rate cuts in the U.S. and UK, investors are keenly observing opportunities that might arise from fluctuating economic in…
As global markets face a mix of challenges, including a record low in U.S. consumer sentiment and heightened scrutiny over AI spending, investors are increasingly focused on identifying undervalued stocks that may offer potential value opp…
CAM2056 showed weight and A1c reductions comparable to or exceeding those seen for weekly semaglutide (Wegovy®) Results include a 9.3% weight reduction with CAM2056 vs. 5.2% with weekly semaglutide at Day 85 Safety and tolerability were co…
As the European markets grapple with concerns about global growth following weak U.S. jobs data and a stronger euro, the pan-European STOXX Europe 600 Index recently ended slightly lower. In this context, identifying stocks that are tradin…
Amid concerns about global growth and a stronger euro, the pan-European STOXX Europe 600 Index recently ended slightly lower, reflecting mixed performance across major European stock indexes. In this context of economic uncertainty and sta…
As European markets navigate a landscape marked by global growth concerns and fluctuating indices, investors are increasingly on the lookout for opportunities that might be undervalued amidst economic uncertainties. In this environment, id…
Amid concerns about the independence of the U.S. Federal Reserve and renewed tariff uncertainties, European markets have faced downward pressure, with major indices like the STOXX Europe 600 Index experiencing declines. As investors naviga…
The European stock market has recently faced challenges, with the pan-European STOXX Europe 600 Index declining amid concerns over U.S. Federal Reserve independence, tariff uncertainties, and political instability in key regions. Despite t…
Amidst a challenging landscape marked by political instability and renewed tariff uncertainties, European markets have recently experienced a downturn, with the pan-European STOXX Europe 600 Index falling nearly 2% as concerns weigh on inv…
As European markets experience a positive shift, with the pan-European STOXX Europe 600 Index rising by 1.40% amid hopes for lower U.S. borrowing costs, investors are increasingly focused on identifying undervalued opportunities. In this e…
As European markets experience a boost from hopes of lower U.S. borrowing costs, with the pan-European STOXX Europe 600 Index rising by 1.40%, investors are keenly eyeing opportunities that might be trading at significant discounts. In suc…
LUND, Sweden, Aug. 28, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization for…
As European markets experience a modest upswing, buoyed by hopes of lower U.S. borrowing costs and an increase in business activity, investors are keenly observing potential opportunities in undervalued stocks. In this environment, identif…
In August 2025, European markets are experiencing a wave of optimism driven by easing trade tensions and potential U.S. interest rate cuts, with the STOXX Europe 600 Index rising by 1.18%. As investors navigate these favorable conditions,…
CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authorities LUND, Sweden, June 18, 2025 /PRNewswire/ -- Ca…
Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) Increased biochemical response rates (IGF-1≤1xULN) vs SoC at baseline Continuous improvement of acromegaly symptom and quality of life scores vs baseline…
LUND, Sweden, June 1, 2020 /PRNewswire/ -- Camurus AB (NASDAQ: CAMX) (STO: CAMX) today announces that the company's US partner Braeburn has submitted a request for final approval of Brixadi™ (buprenorphine) weekly and monthly extended rele…